Literature DB >> 8117295

G12 and G13 alpha-subunits are immunochemically detectable in most membranes of various mammalian cells and tissues.

K Spicher1, F Kalkbrenner, A Zobel, R Harhammer, B Nürnberg, A Söling, G Schultz.   

Abstract

The cDNAs of two putatively pertussis toxin-insensitive G-protein alpha-subunits, alpha 12 and alpha 13, were recently cloned. mRNA analyses based on the reverse transcriptase polymerase chain reaction indicated a widespread distribution of both mRNAs [Strathmann, M. P., and Simon, M. I. (1991) Proc. Natl. Acad. Sci. USA 88, 5582-5586]. Generating specific antibodies directed against internal and C-terminal peptide sequences, we identified alpha 12 protein in all and alpha 13 protein in most tissues and cell lines tested. No species differences were observed, indicating a high degree of identity between mammalian species. Strong immunoreactive signals of both proteins were obtained in neuronal cell membranes of various species. Our results support the hypothesis that G12 and G13 are involved in pertussis toxin-insensitive pathways of signal transduction common to most tissues.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8117295     DOI: 10.1006/bbrc.1994.1129

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  Osteoclastogenic activity and RANKL expression are inhibited in osteoblastic cells expressing constitutively active Gα(12) or constitutively active RhoA.

Authors:  Jun Wang; Paula H Stern
Journal:  J Cell Biochem       Date:  2010-12-15       Impact factor: 4.429

Review 2.  Role of G12 proteins in oncogenesis and metastasis.

Authors:  Juhi Juneja; Patrick J Casey
Journal:  Br J Pharmacol       Date:  2009-04-30       Impact factor: 8.739

3.  Distinct biochemical properties of the native members of the G12 G-protein subfamily. Characterization of G alpha 12 purified from rat brain.

Authors:  R Harhammer; B Nürnberg; C Harteneck; D Leopoldt; T Exner; G Schultz
Journal:  Biochem J       Date:  1996-10-01       Impact factor: 3.857

4.  Adenylyl cyclase inhibition and altered G protein subunit expression and ADP-ribosylation patterns in tissues and cells from Gi2 alpha-/-mice.

Authors:  U Rudolph; K Spicher; L Birnbaumer
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

Review 5.  Receptors and G proteins as primary components of transmembrane signal transduction. Part 2. G proteins: structure and function.

Authors:  B Nürnberg; T Gudermann; G Schultz
Journal:  J Mol Med (Berl)       Date:  1995-03       Impact factor: 4.599

6.  Purification of the G-protein G13 from rat brain membranes.

Authors:  R Harhammer; B Nürnberg; K Spicher; G Schultz
Journal:  Biochem J       Date:  1994-10-01       Impact factor: 3.857

7.  Defective expression of Galpha12 in the testes of azoospermia patients and in the spermatozoa with low motility.

Authors:  Yanqiu Hu; Ying Lu; Zuomin Zhou; Yong Du; Jun Xing; Lei Wang; Min Lin; Jiahao Sha
Journal:  J Mol Med (Berl)       Date:  2006-04-13       Impact factor: 4.599

8.  CCK activates RhoA and Rac1 differentially through Galpha13 and Galphaq in mouse pancreatic acini.

Authors:  Maria E Sabbatini; Yan Bi; Baoan Ji; Stephen A Ernst; John A Williams
Journal:  Am J Physiol Cell Physiol       Date:  2009-11-25       Impact factor: 4.249

9.  Dual bradykinin B2 receptor signalling in A431 human epidermoid carcinoma cells: activation of protein kinase C is counteracted by a GS-mediated stimulation of the cyclic AMP pathway.

Authors:  C Liebmann; A Graness; B Ludwig; A Adomeit; A Boehmer; F D Boehmer; B Nürnberg; R Wetzker
Journal:  Biochem J       Date:  1996-01-01       Impact factor: 3.857

10.  The human thyrotropin receptor: a heptahelical receptor capable of stimulating members of all four G protein families.

Authors:  K L Laugwitz; A Allgeier; S Offermanns; K Spicher; J Van Sande; J E Dumont; G Schultz
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.